Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (221-230 of 333) with videos related to

Pageof 34
Sort By:
Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancerC J Logothetis, K K Wu, L D Finn, et al.
The American Journal of Medicine|September 1, 1984
Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myelomaJ R Quesada, M Hawkins, S Horning, et al.
Experimental Hematology|January 1, 1993
Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineageR Kurzrock, H Kantarjian, M Wetzler, et al.
Cancer Research|June 1, 1990
Effect of recombinant human interleukin 4 on human monocyte activityM M Hudson, A B Markowitz, J U Gutterman, et al.
Cancer Research|July 15, 1988
Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor geneJ S Lee, J S Ro, A Eisbruch, et al.
Human Immunology|May 1, 1981
HLA antigens and immunoglobulin allotypes in patients with malignant melanomaJ P Pandey, A H Johnson, H H Fudenberg, et al.
Cancer Research|June 1, 1985
Modification of human leukocyte interferon pharmacology with a monoclonal antibodyM G Rosenblum, B W Unger, J U Gutterman, et al.
International Journal of Cancer|October 15, 1974
Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvumL Milas, J U Gutterman, I Basic, et al.
International Journal of Immunopharmacology|January 1, 1981
Organ distributions and clearance studies of 99mtechnetium-labeled Corynebacterium parvum in patients with leukemiaH Toki, E M Hersh, J U Gutterman, et al.
Pageof 34

Showing results (221-230 of 333) with videos related to

Sort By:
Pageof 34
Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancerC J Logothetis, K K Wu, L D Finn, et al.
The American Journal of Medicine|September 1, 1984
Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myelomaJ R Quesada, M Hawkins, S Horning, et al.
Experimental Hematology|January 1, 1993
Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineageR Kurzrock, H Kantarjian, M Wetzler, et al.
Cancer Research|June 1, 1990
Effect of recombinant human interleukin 4 on human monocyte activityM M Hudson, A B Markowitz, J U Gutterman, et al.
Cancer Research|July 15, 1988
Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor geneJ S Lee, J S Ro, A Eisbruch, et al.
Human Immunology|May 1, 1981
HLA antigens and immunoglobulin allotypes in patients with malignant melanomaJ P Pandey, A H Johnson, H H Fudenberg, et al.
Cancer Research|June 1, 1985
Modification of human leukocyte interferon pharmacology with a monoclonal antibodyM G Rosenblum, B W Unger, J U Gutterman, et al.
International Journal of Cancer|October 15, 1974
Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvumL Milas, J U Gutterman, I Basic, et al.
International Journal of Immunopharmacology|January 1, 1981
Organ distributions and clearance studies of 99mtechnetium-labeled Corynebacterium parvum in patients with leukemiaH Toki, E M Hersh, J U Gutterman, et al.
Pageof 34